About Generon

Generon is a globally recognized biotechnology company specializing in the research, development, and manufacturing of innovative therapeutics. With a strong focus on oncology, immunology, and rare genetic diseases, Generon's portfolio includes monoclonal antibodies, cell therapies, and gene editing technologies. The company is committed to improving patients' lives through the translation of scientific advancements into effective treatments.